CUE Cue Biopharma, Inc.

NASDAQ
$25.25

Cue Biopharma, Inc. (CUE) SEC Filings

Everything CUE has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

55 filings
Date Form Filing
8-K Investor Presentation · Other · Other Event · Reg Fd
4/A
4/A
SCHEDULE 13D
4
4
4
10-Q
4
4/A
4
4
4
4
4
4
4
4
4
4
4
10-Q
4
4
4
4
10-K
4
4
4
4
4
4
4
4
4
4
10-Q
4
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.